Axogen, Inc. Cash Flow Statement
AXGN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Axogen, Inc. generated $812,000 in operating cash flow and negative free cash flow of $3M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- Negative profit margin: -5.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$15.7M | -$10.0M | -$21.7M | -$28.9M | -$27.0M | -$23.8M | -$29.1M | -$22.4M | -$10.4M | -$14.4M | -$13.4M | -$17.7M | -$9.4M | -$9.4M | -$9.2M |
| Depreciation & Amortization | $6.7M | $6.5M | $4.2M | $2.8M | $2.7M | $1.5M | - | $774.0K | - | $362.0K | - | $153.7K | $187.7K | $187.7K | $273.5K |
| Operating Cash Flow | $812.0K | $4.5M | -$5.7M | -$16.1M | -$13.4M | -$9.6M | -$19.9M | -$17.9M | -$9.2M | -$11.2M | -$13.1M | -$10.5M | -$8.7M | -$8.7M | -$7.1M |
| Capital Expenditures | $3.7M | $3.1M | $13.9M | $20.1M | $27.8M | $21.9M | $4.7M | $6.3M | $1.1M | $931.0K | $408.8K | $542.0K | $48.5K | $48.5K | $20.6K |
| Free Cash Flow | -$2.9M | $1.4M | -$19.6M | -$36.1M | -$41.2M | -$31.5M | -$24.5M | -$24.1M | -$10.3M | -$12.2M | -$13.5M | -$11.0M | -$8.7M | -$8.7M | -$7.1M |
| FCF Margin | -1.3% | 0.8% | -12.3% | -26.1% | -32.4% | -28.1% | -23.0% | -28.8% | -17.1% | -29.6% | -49.3% | -65.4% | -113.2% | -113.2% | -146.4% |